. Author manuscript; available in PMC: 2020 Mar 1.

Published in final edited form as: J Allergy Clin Immunol Pract. 2018 Nov 2;7(3):848–855. doi: 10.1016/j.jaip.2018.10.035

TABLE II.

Frequency of viral infections/reactivations in surviving and deceased patients

Patients	Number of patients with virus infection/reactivation	Time point
Patients	Number of patients with virus infection/reactivation	Early (<day 100)	Late (>day 100)
Surviving (68 of 81)	25 of 68 (37%)	CMV: 15	EBV: 2
		EBV: 4	HSV: 1
		HSV: 3	VZV: 2
		ADV: 4
		HHV6: 1
		BK: 2
		Other: 1
Deceased (13 of 81)	6 of 13 (42%)	CMV: 3	CMV: 1 (persistent)
		EBV: 2	EBV: 1 (persistent)
		HSV: 1	ADV: 1
		HHV6: 1

ADV, Adenovirus; BK, human polyoma virus 1; CMV, cytomegalovirus; HHV6-human herpesvirus 6; HSV-herpes simplex virus; VZV-varicella zoster virus. Note. A single patient may have had multiple viruses. The frequency of virus infection/reactivation was statistically not different between surviving and deceased patients (P = .547).